Solomon Moshkevich Sells Shares of Natera, Inc.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold a total of 3,000 shares of the company's common stock on August 1, 2025. The shares were sold at weighted average prices ranging from $132.4528 to $134.08 per share. The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Moshkevich on November 26, 2024. Following these transactions, Moshkevich's ownership in Natera, Inc. decreased to 123,059 shares. The sales were part of multiple transactions with prices varying within specified ranges, and Moshkevich has committed to providing detailed information on the number of shares sold at each price upon request.